AEs and severe AEs
Events . | n . | Grade . | Subject(s) . |
---|---|---|---|
AEs* | |||
Dizziness | 3 | 1 | 2, 8, 14 |
Dry mouth | 1 | 1 | 2 |
Edema, localized | 1 | 2 | 2 |
Headache | 1 | 2 | 5 |
Insomnia | 4 | 2 | 5, 9, 14, 15 |
Mood swings | 2 | 2, 1 | 5, 9 |
Myalgia | 1 | 1 | 5 |
Nausea | 1 | 2 | 2 |
Palpitations | 2 | 1 | 5, 14 |
Proteinuria | 1 | 1 | 8 |
Rash | 2 | 1, 2 | 2, 15 |
Severe AEs | |||
Squamous cell carcinoma of the skin | 1 | 1 | 7 |
Events . | n . | Grade . | Subject(s) . |
---|---|---|---|
AEs* | |||
Dizziness | 3 | 1 | 2, 8, 14 |
Dry mouth | 1 | 1 | 2 |
Edema, localized | 1 | 2 | 2 |
Headache | 1 | 2 | 5 |
Insomnia | 4 | 2 | 5, 9, 14, 15 |
Mood swings | 2 | 2, 1 | 5, 9 |
Myalgia | 1 | 1 | 5 |
Nausea | 1 | 2 | 2 |
Palpitations | 2 | 1 | 5, 14 |
Proteinuria | 1 | 1 | 8 |
Rash | 2 | 1, 2 | 2, 15 |
Severe AEs | |||
Squamous cell carcinoma of the skin | 1 | 1 | 7 |
All AEs assessed as possibly, probably, or definitely related to study drug are recorded here. These AEs were self-limited, and none led to drug discontinuation. Other AEs are listed in supplemental Table 2.